Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ketotifen plus oral tranexamic acid for facial melasma in women
RBR-10jn7f39Phase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Ketotifen + tranexamic acid with Tranexamic acid + placebo (2 arms). Started Sep 2022; status: completed.
02
Drugs
ketotifentranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on RBR-10jn7f39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10jn7f39.